CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 15 Issue 3

Nanoformulation for Enhanced Drug Delivery and Better Patient Compliance

The increasing occurrence of highly potent or frequent-administration therapies in the drug development pipeline means that the low solubility of drugs is becoming a...
Continue Reading →
Volume 15 Issue 3

Through the Lens of Human Factors: Developing Connected Drug Delivery Devices

Designing Devices for Self-management. The market for drug delivery devices continues to grow at a rapid rate,1 largely due to an expanding elderly population with a...
Continue Reading →
Volume 15 Issue 3

Pharmaceutical Cold Chain Risks and How to Mitigate Them

Shipping temperature-sensitive pharmaceuticals involves a range of risks that can impact the quality, safety, and availability of life-saving treatments for patients...
Continue Reading →
Volume 15 Issue 3

Putting Safety at the Heart of Supplier Controls

Marketing authorisation holders’ responsibility for ensuring the continuous monitoring of the safety of a medicinal product across the marketing authorisation lifecy...
Continue Reading →
Volume 15 Issue 3

What Does the Future of Temperature-controlled PharmaSupply Chain Look Like and How Do We Shape It?

Importance of Airfreight for the Pharma Industry Airfreight plays a vital role in the pharmaceutical industry, especially for economically export-oriented countri...
Continue Reading →
Volume 15 Issue 3

The Great Why Questions About Dry Powder Inhalers

The research pertains to the economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation techniques with commonly prescribe...
Continue Reading →
Volume 15 Issue 3

Clinical Gamma Scintigraphy for the Evaluation of Inhaled Medicine

IPI Speaks with Dr. Simon Warren, Research Director at Cardiff Scintigraphics on the benefits ofscintigraphic evaluation in respiratory drug delivery. Q: Cardiff ...
Continue Reading →
Volume 15 Issue 3

Vaping – Success or Disaster?

This month disposable vapes (also known as e-cigarettes) have hit the headlines – this time we have finally woken up to the fact that millions of disposable vapes ar...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026